文献速递冠心病血脂与心血管预防

糖尿病多支冠状动脉病变血运重建策略的个体化风险预测

Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease.
PubMed 文献 · J Am Coll Cardiol · 2019-01-01

基于FREEDOM试验1900例糖尿病多支冠状动脉病变患者数据,开发预测5年主要不良心血管事件(MACE)和1年心绞痛的个体化风险模型,以支持CABG与PCI的共享决策。MACE模型含8个变量及吸烟状态交互项(c=0.67),心绞痛模型含6个变量及SYNTAX评分交互项(c=0.67)。PCI从未优于CABG,CABG在54.5%患者中MACE优于PCI,吸烟者中达100%。

要点

  • 个体化风险模型可预测糖尿病多支病变患者CABG与PCI后的5年MACE和1年心绞痛。
  • PCI从未优于CABG,CABG在54.5%患者中MACE更优,吸烟者中100%更优。
  • 模型经内部bootstrap验证和外部注册库验证,区分度良好。

核心结论

  • 创建了个体化风险预测工具,用于糖尿病多支冠状动脉病变患者CABG与PCI的共享决策。

研究设计与样本

  • 使用FREEDOM试验1900例患者数据,开发预测5年MACE和1年心绞痛的模型,含基线协变量和治疗交互项。

主要发现

  • 5年MACE发生346例(18.2%),1年心绞痛310例(16.3%)。
  • MACE模型含8个变量及吸烟状态交互项,c=0.67;外部验证稳定CAD c=0.65,ACS c=0.68。
  • 心绞痛模型含6个变量及SYNTAX评分交互项,c=0.67。
  • PCI从未优于CABG,CABG在54.5%患者中MACE优于PCI,吸烟者中100%优于PCI。

临床怎么用

  • 可用于评估每位患者接受CABG或PCI的个体化结局,辅助共享决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In patients with diabetes and multivessel coronary artery disease (CAD), the FREEDOM (Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease) trial demonstrated that, on average, coronary artery bypass grafting (CABG) was superior to percutaneous coronary intervention (PCI) for major acute cardiovascular events (MACE) and angina reduction. Nonetheless, multivessel PCI remains a common revascularization strategy in the real world. OBJECTIVES: To translate the results of FREEDOM to individual patients in clinical practice, risk models of the heterogeneity of treatment benefit were built. METHODS: Using patient-level data from 1,900 FREEDOM patients, the authors developed models to predict 5-year MACE (all-cause mortality, nonfatal myocardial infarction, and nonfatal stroke) and 1-year angina after CABG and PCI using baseline covariates and treatment interactions. Parsimonious models were created to support clinical use. The models were internally validated using bootstrap resampling, and the MACE model was externally validated in a large real-world registry. RESULTS: The 5-year MACE occurred in 346 (18.2%) patients, and 310 (16.3%) had angina at 1 year. The MACE model included 8 variables and treatment interactions with smoking status (c = 0.67). External validation in stable CAD (c = 0.65) and ACS (c = 0.68) demonstrated comparable performance. The 6-variable angina model included a treatment interaction with SYNTAX score (c = 0.67). PCI was never superior to CABG, and CABG was superior to PCI for MACE in 54.5% of patients and in 100% of patients with history of smoking. CONCLUSIONS: To help disseminate the results of FREEDOM, the authors created a personalized risk prediction tool for patients with diabetes and multivessel CAD that could be used in shared decision-making for CABG versus PCI by estimating each patient's personal outcomes with both treatments.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Qintar M, Humphries KH, Park JE, et al. Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease. J Am Coll Cardiol. 2019. PMID: 31623766. doi:10.1016/j.jacc.2019.07.083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。